Global Glucosamine Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 581.60 Billion |
 Market Size (Forecast Year) |
USD 923.01 Billion |
 CAGR |
% |
| Major Markets Players |
|
全球葡萄糖胺市场，按类型（盐酸葡萄糖胺、氯化钾硫酸葡萄糖胺、氯化钠硫酸葡萄糖胺、N-乙酰葡萄糖胺）、剂量（粉末、片剂、胶囊、液体）、给药途径（外用、肌肉注射、口服）、应用（类风湿性关节炎、哮喘、糖尿病、高胆固醇、骨关节炎、炎症性肠病、其他）、最终用户（诊所、医院、其他）、分销渠道（医院药房、零售药房、网上药房）划分 - 行业趋势和预测到 2030 年。
葡萄糖胺市场分析和规模
类风湿性关节炎患病率上升、治疗方案的进步以及意识的提高是扩大全球葡萄糖胺市场的因素。素食葡萄糖胺的开发至关重要，因为许多人正在转向纯素饮食以过上更健康的生活方式，因为它是一种素食友好的配方，素食葡萄糖胺是最安全的素食关节补充剂之一。此外，不断增加的研发活动、正在进行的临床试验和新兴市场将在预测期内为葡萄糖胺市场进一步创造新的机会。
Data Bridge Market Research 分析称，2022 年氨基葡萄糖市场规模为 5.816 亿美元，到 2030 年将达到 9.2301 亿美元，预计在 2023 年至 2030 年的预测期内复合年增长率为 6.1%。由于需求不断增长，“医院”在氨基葡萄糖市场的终端用户细分市场中占据主导地位。除了对市场价值、增长率、细分市场、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
葡萄糖胺市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
按类型（盐酸氨基葡萄糖、氯化钾硫酸氨基葡萄糖、氯化钠硫酸氨基葡萄糖、N-乙酰氨基葡萄糖）、剂量（粉末、片剂、胶囊、液体）、给药途径（外用、肌肉注射、口服）、应用（类风湿性关节炎、哮喘、糖尿病、高胆固醇、骨关节炎、炎症性肠病、其他）、最终用户（诊所、医院、其他）、分销渠道（医院药房、零售药房、网上药房） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
Bio-gen Extracts Private Limited (India), Panvo Organics Pvt Ltd (India), Pharma Base S.A. (Switzerland), CAPTEK Softgel International Inc. (U.S.), TSI GROUP LTD (Australia), Cargill, Incorporated (U.S.), CELLMARK AB. (Sweden), Zhejiang Zhoushan Putuo Xinxing Pharmas Co. Ltd. (PXPC) (China), Andra Medi Pharma Pvt. Ltd (India), Jiaxing Hengjie Biopharmaceutical Co., Ltd. (China), Spectrum Chemical Manufacturing Corp. (U.S.), RB Health LLC (U.S.), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), among other |
|
Market Opportunities |
|
Market Definition
Glucosamine is a natural compound found in cartilage and made from fructose and the amino acid glutamine. It is important for the production of glycosaminoglycan, which is a molecule used in the formation and repair of cartilage and other body tissues. In supplement form, glucosamine is an amino sugar that is produced by the hydrolysis of shellfish or manufactured in labs by the fermentation process of grains such as wheat and corn.
Global Glucosamine Market Dynamics
Drivers
- Increasing prevalence of osteoarthritis
Rising prevalence of osteoarthritis attribute to the increased adoption of the drug for the treatment of disease across the globe. People are now increasingly adopting the therapy for the treatment as they are more convenient, effective. Growing cases of arthritis around the world are raising awareness about the benefits of glucosamine, is propelling the growth of the market. Arthritis affects almost 54 million people in the United States. As shown in a Centre for Disease Control and Prevention analysis, the proportion of the population with arthritis is already on the rise, with over 78 million predicted by 2040. This obesity is also known to be a factor helping the penetration of glucosamine in the world. Over 1.9 billion people over the age of eighteen were overweight in 2016. If glucosamine is used in one's diet, it can support them lose weight while also improving joint stability.
The World Health Organization (WHO) estimates that between 10% to 15% of the population aged 60 years and above have some form of osteoarthritis. Also, the awareness level of the general population towards health and wellness supplements, especially those used for bone and joint health is high. These factors are increasingly driving the market.
- Increased usage of bone and joint health supplements
Maintaining a healthy lifestyle and preventing bone diseases is making consumers pay premium prices for glucosamine supplements, as they impart health benefits, targeting treatment of a specific segment of the human body. The essential properties of glucosamine have encouraged the manufacturers to introduce new products and, thus, lead to the overall growth of the glucosamine market.
The World Health Organization (WHO) has estimated that almost 22 million individuals in Europe and 14 million in the United States alone will be suffering from osteoporosis.
- Rising number of geriatric population
Expanding geriatric population worldwide is predicted to favour glucosamine demand as this population is more prone to chronic diseases. The number of persons above 65 years is projected to double in the coming years. Old age people are prone to various chronic diseases which can foster the demand for glucosamine across the globe.
Bone and Joint Health Supplements target the aging population and the percentage of population above the age of 65 is significantly high in regions such as North America and Europe.
According to the United Nations, there were around 382 million old age people, aged 60 years or above, across the globe in 2017 and this number is expected 2.1 billion by 2050.
Opportunity
- Rise in government funds and support.
Furthermore, an increase in government funds and support for target research activities, rising clinical trials and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2023 to 2030.The demand for specialized treatment is projected to drive the glucosamine market growth. These developments are anticipated to expedite the market expansion for glucosamine in the future.
Restrain/Challenge
- High cost of products
On the other hand, high cost of products is expected to restrain the market. The special manufacturing processes can make these molecules more absorbable. Naturally, that special processing costs money, making the “good quality”, readily absorbed, products more expensive to purchase. The various side effects of glucosamine such as heartburn, drowsiness, and headache are the factors that will hamper the global glucosamine market growth. Moreover, volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will further challenge the glucosamine market in the forecast period of 2023-2030.
This glucosamine market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the glucosamine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2021, Nestle China launched its first set of ‘blue-hat’ certified health foods for seniors – a milk powder containing glucosamine and a probiotic protein powder. This results in expanding the product portfolio of the company.
Global Glucosamine Market Scope
The glucosamine market is segmented on the basis of type, dosage, route of administration, application, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Glucosamine Hydrochloride
- Glucosamine Sulfate Potassium Chloride
- Glucosamine Sulfate Sodium Chloride
- N-acetyl Glucosamine
Dosage
- Powder
- Tablets
- Capsule
- Liquid
Route of Administration
- Topical
- Intramuscular
- Oral
Application
- Rheumatoid Arthritis
- Asthma, Diabetes
- High cholesterol
- Osteoarthritis
- Inflammatory Bowel Disease
- Others
End-User
- Hospitals
- Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Glucosamine Market Regional Analysis/Insights
The global glucosamine market is analyzed and market size insights and trends are provided by country, type, dosage, route of administration, application, end-users and distribution channel as referenced above.
The countries covered in the glucosamine market report are the U.S., Canada, and Mexico in North America, Germany, France, the U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the glucosamine market due to the presence of major key players, continuous technological development, a well-developed healthcare sector, increasing prevalence of disease and increasing awareness towards health in this region.
由于研发活动的增加、新兴市场的出现、医疗保健领域的投资不断增加以及政府对该地区的支持不断增加，预计亚太地区将在 2023 年至 2030 年的预测期内实现最高增长率。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
葡萄糖胺市场还为您提供每个国家/地区资本设备医疗保健支出增长、葡萄糖胺市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对葡萄糖胺市场的影响的详细市场分析。数据适用于 2010-2021 年的历史时期。
竞争格局和葡萄糖胺市场份额分析
葡萄糖胺市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对葡萄糖胺市场的关注有关。
葡萄糖胺市场的一些主要参与者包括：
- Spectrum Chemical Manufacturing Corp.（美国）
- RB Health LLC（美国）
- Mylan NV（美国）
- CAPTEK Softgel International Inc.（美国）
- TSI 集团有限公司 (澳大利亚)
- 嘉吉公司（美国）
- Teva Pharmaceutical Industries Ltd.（以色列）
- Bio-gen Extracts Private Limited（印度）
- Panvo Organics Pvt Ltd (印度)
- Pharma Base SA（瑞士）
- CELLMARK AB.（瑞典）
- 浙江舟山普陀新兴制药有限公司 (PXPC)（中国）
- 安德拉医疗制药列兵。有限公司（印度）
- 嘉兴恒杰生物制药有限公司 (中国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
